Dermal Fillers: Materials, Risks and Questions for a Qualified Practitioner

Dermal fillers are injectable materials used to alter volume or contour. The choice involves more than selecting a brand or booking a treatment area: the material, your medical history, the practitioner’s experience and the arrangements for complications all matter.

“Temporary” and “non-surgical” do not mean risk-free. A useful consultation should explain what the proposed product can reasonably achieve, what it cannot achieve and why doing nothing may also be an appropriate choice. This guide supports that discussion without providing injection instructions.

Key takeaways

• Fillers contain different materials and are not interchangeable.
• Ask for the exact product, intended use, risks and practitioner qualifications.
• Removal can be difficult and has risks; reversibility should not be promised casually.
• Unusual pain, skin colour change or visual symptoms require immediate medical attention.
• Take time to decide and obtain a clear aftercare and emergency contact plan.

On this page

1. Understand the material being proposed
2. Do not confuse overseas approval with a UK suitability assessment
3. Have the consultation before committing
4. Understand both common and serious risks
5. Know which symptoms need immediate action
6. Ask what removal would actually involve
7. Plan the practical side
8. Common questions
9. Sources and further reading

Understand the material being proposed

Hyaluronic acid, often shortened to HA, is one filler material. Other types include calcium hydroxylapatite, poly-L-lactic acid and polymethylmethacrylate, or PMMA. Their properties, intended uses and persistence differ. A familiar ingredient name on a skincare bottle does not make an injectable product equivalent to a topical cosmetic.

The US Food and Drug Administration describes absorbable and non-absorbable filler materials. HA is generally supplied as a gel; calcium hydroxylapatite uses mineral particles in a gel carrier; poly-L-lactic acid has effects that develop over time; PMMA contains non-absorbable microspheres. These categories are background information, not a recommendation for a particular area.

Ask which exact product is being offered and why it is suitable for the proposed purpose. Some products also contain local anaesthetic. Tell the clinician about allergies and previous reactions, and ask for the product’s patient information rather than relying only on a promotional brochure.

Do not confuse overseas approval with a UK suitability assessment

FDA approval refers to the United States and to particular products and uses. It is not a blanket statement that a product is approved for every body area, every patient or every use in the UK. This article uses FDA material to explain product differences and safety concerns, not to describe UK licensing rules.

If an advertisement mentions a regulator, ask what the statement actually covers. The practitioner should still explain the product’s status and intended use in your setting. A regulatory logo or a well-known brand does not establish the training of the person holding the syringe.

Our practitioner-qualification guide helps you check the relevant professional register and understand its limits. Registration, treatment-specific competence and the ability to manage complications are related questions, but one should not be assumed from another.

Have the consultation before committing

NHS advice recommends choosing a suitably qualified, experienced and insured practitioner and taking time over a cosmetic decision. A consultation should include your reasons for considering treatment, medical history, alternatives and possible outcomes. You should have an opportunity to ask questions without pressure to book immediately.

Bring details of previous injectable treatments, including product names and dates if you have them. Mention medicines, allergies, skin problems and relevant past complications. If you do not know what was previously injected, say so rather than guessing; ask how that uncertainty affects the plan.

Use our first-consultation questions to organise the conversation. Ask whether the proposed result is realistic, what cannot be changed and whether a different approach or no treatment would better fit your priorities.

Understand both common and serious risks

The FDA lists bruising, swelling, redness, tenderness and pain among common reactions. Infection, nodules and delayed inflammation can also occur. Some problems arise later, so a comfortable first few days does not remove the need to report a subsequent concern.

A rare but serious complication is unintended injection into a blood vessel, which can obstruct blood supply. Reported consequences include tissue death, blindness and stroke. A consultation that discusses only temporary bruising does not provide a complete picture of risk.

Ask how risks differ for the proposed site and what the practitioner will do if something goes wrong. This is not a request for a technical injection demonstration. It is a request to understand the clinical safeguards, access to assessment and practical emergency arrangements before deciding.

Know which symptoms need immediate action

Seek immediate medical attention for unusual pain, a white, grey or blue appearance near the injection site, or visual changes during or shortly after treatment. Sudden sight loss or symptoms of stroke require emergency care: call 999. Do not wait for an online message to be answered.

Contact the treating practitioner promptly about a suspected complication, but do not let that contact delay emergency help. Our post-procedure warning-sign guide explains why worsening or unexpected symptoms need assessment rather than reassurance from a generic recovery timeline.

Before leaving the appointment, ask for written instructions and the out-of-hours route. Save the details somewhere accessible. If another clinician assesses you later, tell them what was injected, when and where, and provide the product record if available.

Ask what removal would actually involve

Some fillers may be reduced or removed, but this can require further procedures and carries additional risks. The FDA warns that removal may be difficult or impossible, particularly with permanent materials. Do not interpret “we can reverse it” as a guarantee of a simple, complete or risk-free return to the starting point.

Ask what options exist for the specific material and which problems those options can address. Dissatisfaction with appearance and an urgent medical complication are different situations. Neither should be managed by buying injectable products or attempting a correction at home.

Plan the practical side

Request a written quote covering the proposed treatment, review appointments and the policy for complications or further assessment. Ask who provides follow-up if the original practitioner is away. A discounted package has little value if you do not understand what ongoing care it includes.

Keep your decision separate from a same-day promotion. Being able to explain the product, the main risks and the contact plan in your own words is a useful check of whether the consultation has answered your questions. If important points remain unclear, take more time before proceeding.

Common questions

Are all fillers made from hyaluronic acid?

No. Several materials are used. Ask for the exact product rather than assuming that every filler has the same properties.

Does temporary mean harmless?

No. How long a material persists and the risks of administering it are different questions.

Does FDA approval apply automatically in the UK?

No. FDA information describes the US framework. Ask about the proposed product and use in your own clinical setting.

Can every filler be dissolved?

No. Removal options depend on the material and circumstances, and further treatment has its own limitations and risks.

Can I use an online filler kit?

Do not inject yourself or attempt a home correction. Assessment and treatment require an appropriately trained healthcare professional.

What if vision changes after treatment?

Seek immediate medical help. Sudden sight loss is an emergency; call 999 and explain the recent procedure.

Should I mention old filler?

Yes. Share known products, dates, areas and problems. Be clear about any details you cannot confirm.

Must I decide at the consultation?

No. Take the time you need to understand the proposal and alternatives. Choosing not to proceed remains an option.

Sources and further reading

Sources checked 22 October 2026. FDA material is explicitly presented in its US context. No injection technique or guarantee of reversal is provided. Clinical review is not claimed.

• FDA: dermal filler risks and patient information
• FDA: filler materials and product-specific information
• NHS: before a cosmetic procedure
• NHS: stroke symptoms and emergency action